EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
- 19 June 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer and Metastasis Reviews
- Vol. 31 (3-4), 753-761
- https://doi.org/10.1007/s10555-012-9387-3
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Coordinated Regulation of Polycomb Group Complexes through microRNAs in CancerCancer Cell, 2011
- FGF-2 Regulates Cell Proliferation, Migration, and Angiogenesis through an NDY1/KDM2B-miR-101-EZH2 PathwayMolecular Cell, 2011
- Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damageCell Death & Differentiation, 2011
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin SignalingCancer Cell, 2011
- Regulation of Tumor Angiogenesis by EZH2Cancer Cell, 2010
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κBNature Medicine, 2010
- Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell linesThe Prostate, 2010
- Epigenetic gene regulation in stem cells and correlation to cancerDifferentiation, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- The Hallmarks of CancerCell, 2000